Background. The utility of EUS was evaluated for detection of ascites and E
US-guided FNA of ascites in patients undergoing EUS for diagnosis and stagi
ng of GI malignancies.
Methods: A series (from March 1994 to October 1997) of 571 consecutive pati
ents who underwent upper EUS for various indications was retrospectively re
viewed. Follow-up clinical information was obtained from referring physicia
ns, subsequent CT, and telephone interviews.
Results: Eighty-five patients (15% of series) were found to have ascites by
EUS. Six did not have CT before EUS. Pre-EUS CT identified ascites in only
14 (18%) of the 79 patients who had pre-EUS CT. Of the patients in whom CT
was negative for abdominal fluid (n = 65) and who had clinical follow-up,
13 of 58 (22%) subsequently had ascites develop that were detected by CT or
physical examination. Overall, 31 of the 85 patients underwent EUS-guided
FNA paracentesis; the mean volume obtained was 7.9 mL (range 1-40 mL). In 5
patients, malignant ascites was diagnosed by EUS-guided FNA; in these pati
ents surgery was avoided.
Conclusions: EUS is more sensitive than CT in detecting small amounts of as
cites. A significant number (22%) of patients who had ascites by EUS subseq
uently had ascites develop that was detectable by CT or physical examinatio
n. EUS-guided paracentesis appears to be safe and effective and can identif
y malignant ascites.